Author:
Yuan Dandan,Zhai Xiaoyang,Zhu Kunli,Ji Jiangang,Liu Wenjuan
Funder
Key Technology Research and Development Program of Shandong
Natural Science Foundation of Shandong Province
Reference25 articles.
1. Tuftsin: its chemistry, biology, and clinical potential;Fridkin;Crit. Rev. Biochem. Mol. Biol.,1989
2. Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation, CANCER IMMUNOL IMMUN;Liu;Cancer Immunol. Immunother.,2014
3. Tuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino mice;Khan;Mol. Med.,2007
4. Targeted drug delivery using tuftsin-bearing liposomes: implications in the treatment of infectious diseases and tumors;Khan;Curr. Drug Targets,2021
5. Treatment effect of tuftsin and antigen peptide combined with immune cells on colorectal cancer;Zou;Med. Sci. Mon. Int. Med. J. Exp. Clin. Res.,2019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献